| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/08/2006 | EP1631237A2 Proteoglycan degrading mutants for treatment of cns |
| 03/08/2006 | EP1631234A2 Compositions and methods for the treatment of cns injuries |
| 03/08/2006 | EP1631155A1 Method for producing a chitosan containing salt having a function of lowering blood pressure |
| 03/08/2006 | EP1631146A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 03/08/2006 | EP1631145A2 P38 kinase inhibitor compositions and methods of using the same |
| 03/08/2006 | EP1556397B1 9a-azalides with anti-inflammatory activity |
| 03/08/2006 | EP1539734B1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/08/2006 | EP1534342B1 Modified saccharides, conjugates thereof, and their manufacture |
| 03/08/2006 | EP1505997B1 Formulations useful in the treatment of male and female impotence |
| 03/08/2006 | EP1503775B1 Formulations useful in the treatment of male and female impotence |
| 03/08/2006 | EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1472290A4 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 03/08/2006 | EP1465627B1 DOSING REGIMEN FOR PPAR−GAMMA ACTIVATORS |
| 03/08/2006 | EP1461017B1 A pharmaceutical composition for controlled release of a beta-lactam antibiotic |
| 03/08/2006 | EP1455602B1 Modified methionine rich food products and process for their manufacture |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1445252B1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 03/08/2006 | EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 03/08/2006 | EP1406628B1 Tetrahydroquinoline derivatives |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1390377B1 New crystal form of azithromycin |
| 03/08/2006 | EP1390371B1 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 03/08/2006 | EP1387841B1 Novel azole or triazole derivatives, method for preparing the same and use thereof as fungicides |
| 03/08/2006 | EP1387839B1 Process for the production of quinazolines |
| 03/08/2006 | EP1385821A4 Novel anti-adhesive compounds and uses thereof |
| 03/08/2006 | EP1385497B1 Prevention or treatment of breast, prostate and/or cervical cancer with n,n-dimethylglycine |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1363895B1 Process for the production of tocotrienols |
| 03/08/2006 | EP1353926B1 Mikanolide derivatives, their preparation and therapeutic uses |
| 03/08/2006 | EP1349853B1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1347756B1 Controlled release of anti-arrhythmic agents from a biodegradable hydrogel for local application to the heart |
| 03/08/2006 | EP1347753B1 Topical composition and method for treating urinary stress incontinence |
| 03/08/2006 | EP1347747B1 Method for preparing submicron particle suspensions of pharmaceutical agents |
| 03/08/2006 | EP1347743B1 Composition for treatment of inflammatory disorders |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents |
| 03/08/2006 | EP1326589B1 Nanoparticles |
| 03/08/2006 | EP1326585B1 Method for producing powdery formulations |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1299090B1 Oral pharmaceutical composition with controlled release and prolonged absorption |
| 03/08/2006 | EP1280559B1 Acylated cyclodextrin guest inclusion complexes |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1276503B1 Screening methods for inhibitors of an acrab and an acrab-like efflux pump |
| 03/08/2006 | EP1274674B1 Choline derivatives for the treatment of alzheimer's disease |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1267886B1 Vitamin d compounds for the treatment of chronic allograft nephropathy in kidney transplant patients |
| 03/08/2006 | EP1263422B1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) |
| 03/08/2006 | EP1244670B1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 03/08/2006 | EP1242411B1 Indole derivatives for the treatment of depression and anxiety |
| 03/08/2006 | EP1241955B1 Drinkable omega-3 preparation |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/08/2006 | EP1237532B1 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 03/08/2006 | EP1234576B1 Pharmaceutical composition for eating disorders |
| 03/08/2006 | EP1230338B1 Continuous-flow method for preparing microparticles |
| 03/08/2006 | EP1223913B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 03/08/2006 | EP1206261B1 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 03/08/2006 | EP1198454B1 Mutilin derivatives and their use as antibacterials |
| 03/08/2006 | EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes |
| 03/08/2006 | EP1176959B1 Novel prolines as antimicrobial agents |
| 03/08/2006 | EP1133325B1 Coating useful as a dispenser of an active ingredient on dressings and bandages |
| 03/08/2006 | EP1110554B1 Medicinal compositions for treating eye diseases |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP1087781B1 Dietary supplement for supporting cerebrovascular tone |
| 03/08/2006 | EP1079806B1 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear |
| 03/08/2006 | EP1075265B1 Use of tetracyclines for treating meibomian gland disease |
| 03/08/2006 | EP1071430B1 Treatment of iatrogenic and age-related hypertension with vitamin b6 derivatives and pharmaceutical compositions useful therein |
| 03/08/2006 | EP1044186B1 Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 03/08/2006 | EP1041995B1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 03/08/2006 | EP1039902B1 Inhibitors of gap junction communication |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1032662B1 Methods and compositions for immunomodulation |
| 03/08/2006 | EP1005460B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/08/2006 | EP0988310B9 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 03/08/2006 | EP0977568B1 Benzocycloheptathiophene compounds |
| 03/08/2006 | EP0954298B1 2,5-dihydroxybenzenesulfonic derivatives for the treatment of sexual dysfunction |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | EP0938476B1 Process for substituted pyridines |
| 03/08/2006 | EP0910628B1 Inactivation resistant factor viii |
| 03/08/2006 | EP0889727B1 Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 03/08/2006 | EP0877735B1 Polycyclic compounds |
| 03/08/2006 | EP0870039B1 Recombinant fusion proteins to growth hormone and serum albumin |
| 03/08/2006 | EP0841945B1 Cell derived antigen presenting vesicles |
| 03/08/2006 | EP0804148B1 Lipophilic hydroxylated acid, cosmetic and pharmaceutical use thereof and method for preparing same |
| 03/08/2006 | EP0736029B1 Anticonvulsant pseudofructopyranose sulfamates |
| 03/08/2006 | EP0659216B1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 03/08/2006 | EP0596049B1 Defoaming composition |
| 03/08/2006 | CN2762821Y High polymer multiporous energy accumulation ion acupoint treatment plaster |
| 03/08/2006 | CN1745090A Steroid compounds with anti-tumor activity |
| 03/08/2006 | CN1745087A Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 03/08/2006 | CN1745085A Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 03/08/2006 | CN1745083A Pyrrolo[2,1-c][1,4] benzodiazepines as vasopressin agonists |
| 03/08/2006 | CN1745081A Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745078A Pyridine derivatives useful for inhibiting sodium/calcium exchange system |